** Shares of British consumer healthcare group Haleon HLN.L down 2.3% at 348.5p
** Stock among top losers on FTSE 100 index .FTSE, which is up 13.3% YTD
** Barclays downgrades co's rating to "Equal Weight" from "Overweight", cuts PT to 380p from 430p
** Brokerage says the main issue HLN has is the U.S. which remains very challenging
** Adds that co is seeing both consumer slowdown and destocking pressures in the U.S.
** Says have concerns about near-term outlook in Latin America, driven by macro weakness in Europe amid pricing pressure in Germany
** Ten of the 18 analysts covering the stock have a "Buy" or higher rating, seven have "Hold", while one rates it at "Sell"; median PT is 425p- data compiled by LSEG
** Including session's losses, stock down 7.84%, YTD
(Reporting by Ankita Bora in Bengaluru)
((Ankita.Bora@thomsonreuters.com))